The cost-effectiveness analysis of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair deficient advanced colorectal cancer.

This study evaluated the cost-effectiveness of first-line immunotherapy versus chemotherapy for patients with MSI‑H/dM...

Continue ReadingThe cost-effectiveness analysis of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair deficient advanced colorectal cancer.